Partnering News

03.17.2017

DILIsym Services, Inc. Evaluates Prospective NAFLD Treatment, Utilizing Its Flagship Technology in Collaboration with Pfizer, Inc.

03.01.2017

Spark Therapeutics and Pfizer Announce that SPK-9001, an Investigational Hemophilia B Medicine, has been Granted Access to the PRIority MEdicines (PRIME) Program by the European Medicines Agency

02.28.2017

Pfizer Commits $4M to North Carolina Biotechnology Center Gene Therapy Fellowship Program

02.27.2017

Arrakis Therapeutics Announces $38M Series A Financing To Target RNA with Small-Molecule Medicines And Names Michael Gilman Chairman and CEO

02.22.2017

Startup accelerator BaseLaunch aims to attract promising healthcare ventures to Basel, Europe’s leading life sciences hub.

01.31.2017

Edelris Announces Research Collaboration Agreement with Pfizer Inc.

01.19.2017

Milner Therapeutics Institute announces new partnership with US pharmaceutical company Pfizer

01.10.2017

The Scripps Research Institute Signs Collaboration Agreement with Pfizer to Advance DNA-Encoded Library Technology

01.06.2017

Guardant Health to create a new 500-plus-gene liquid biopsy panel with several leading pharmaceutical companies to accelerate clinical trials and drug development

01.05.2017

Iterum Announces Sulopenem in Development for Treatment of Gram-Negative, Multi-drug Resistant Infections

01.05.2017

Molecular Stethoscope Completes $8.2M Seed Financing to Advance Circulating Cell-Free RNA Liquid Biopsy Platform; Announces Research Collaboration with Pfizer

01.05.2017

AbCellera Announces Multi-Target Research Collaboration with Pfizer